Zhenyu Ding Selected Research

Zhenyu Ding Research Topics

Disease

23	Neoplasms (Cancer) 04/2023 - 08/2006
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 05/2014
6	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2017
5	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2018
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2009
4	Colonic Neoplasms (Colon Cancer) 12/2022 - 08/2006
3	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2021
3	Esophageal Neoplasms (Esophageal Cancer) 04/2023 - 04/2013
3	Disease Progression 06/2022 - 08/2013
3	Adenocarcinoma of Lung 01/2022 - 07/2017
3	Brain Neoplasms (Brain Tumor) 12/2018 - 05/2014
3	Hypoxia (Hypoxemia) 02/2017 - 11/2010
3	Carcinogenesis 01/2015 - 06/2009
3	Colorectal Neoplasms (Colorectal Cancer) 04/2013 - 09/2009
2	Infections 11/2021 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021 - 07/2017
2	Hypertension (High Blood Pressure) 10/2020 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 08/2013
2	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2022
1	Endocrine System Diseases (Endocrine Diseases) 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Osteoarthritis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Squamous Cell Carcinoma of Head and Neck 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2021
1	Complementation Group C Xeroderma Pigmentosum 01/2021
1	Angina Pectoris 10/2020
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Myocardial Infarction 10/2020
1	Inflammation (Inflammations) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Coronavirus Infections 01/2020
1	Hand-Foot Syndrome 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	COVID-19 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 04/2019
1	Dermatofibrosarcoma 04/2019
1	Radiation Pneumonitis 01/2019
1	Chronic Renal Insufficiency 04/2018
1	Pleural Effusion (Pleural Effusions) 01/2018

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2011
6	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 12/2022 - 11/2010
4	VaccinesIBA 01/2021 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2012
3	AntigensIBA 12/2020 - 06/2011
2	Gemcitabine FDA Link 01/2022 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
2	apatinibIBA 01/2020 - 04/2019
2	AntibodiesIBA 02/2018 - 08/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 11/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2022
1	mRNA VaccinesIBA 12/2022
1	osimertinibIBA 01/2022
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2022
1	SugarsIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	GelatinIBA 10/2021
1	pirfenidoneIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Programmed Cell Death 1 ReceptorIBA 02/2021
1	Long Noncoding RNAIBA 01/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 12/2020
1	anlotinibIBA 10/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	PlatinumIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	CrizotinibIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2019
1	CreatinineIBA 04/2018
1	Cystatin CIBA 04/2018
1	Bevacizumab (Avastin)FDA Link 04/2018
1	EndostatinsIBA 01/2018
1	NivolumabIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Durapatite (Hydroxylapatite)IBA 02/2017
1	Phosphocreatine (Neoton)IBA 02/2017

Therapy/Procedure

10	Immunotherapy 12/2022 - 06/2009
10	Therapeutics 01/2022 - 06/2011
8	Drug Therapy (Chemotherapy) 11/2023 - 01/2014
5	Radiotherapy 01/2019 - 05/2014
3	Neoadjuvant Therapy 11/2023 - 01/2022
1	Induction Chemotherapy 01/2022
1	Adjuvant Radiotherapy 04/2019
1	Chemoradiotherapy 01/2018
1	Microspheres (Microsphere) 02/2017